Limitations of brain imaging in forensic psychiatry

Journal of the American Academy of Psychiatry and the Law

Volumn 31, Issue 1, 2003, Pages 89-96

  Reeves, Donald ^a   Mills, Mark J ^b   Billick, Stephen B ^c   Brodie, Jonathan D ^d  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b Metropolitan Police Department   (United States)

^c NEW YORK MEDICAL COLLEGE   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN; COMPUTER ASSISTED TOMOGRAPHY; COURT; EXPERT WITNESS; FORENSIC PSYCHIATRY; GABAERGIC SYSTEM; HUMAN; IMAGING SYSTEM; MAGNETOENCEPHALOGRAPHY; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANTIPSYCHOTIC AGENTS; BRAIN; ELECTROENCEPHALOGRAPHY; FORENSIC PSYCHIATRY; GAMMA-AMINOBUTYRIC ACID; HALOPERIDOL; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETOENCEPHALOGRAPHY; MONOAMINE OXIDASE INHIBITORS; NEURONS; SCHIZOPHRENIA; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0037244658     PISSN: 10936793     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (27)

1. Wellcome Department of Cognitive Neurology: Statistical Parametric Mapping. London: University College of London; available at www.fil.ion.uci.ac.uk/spm; accessed September 2002
2. Brodie JD: Imaging for the clinical psychiatrist: facts, fantasies, and other musings [editorial]. Am J Psychiatry 153:145-9, 1996
3. Buchel C, Holmes AP, Rees G, et al: Characterizing stimulusresponse functions using nonlinear regressors in parametric fMRI experiments. Neuroimage 8:140-8, 1998
4. Fletcher PC, Dolan RJ, Shallice T, et al. Is multivariate analysis of PET data more revealing than the univariate approach? -evidence from a study of episodic memory retrieval. Neuroimage 3:209-15, 1996
5. Poline JB, Worsley KJ, Evans AC, et al: Combining spatial extent and peak intensity to test for activations in functional imaging. Neuroimage 5:83-96, 1997
6. Signorini M, Paulesu E, Friston K, et al: Rapid assessment of regional cerebral metabolic abnormalities in single subjects with quantitative and nonquantitative [18F]FDG PET: a clinical validation of statistical parametric mapping. Neuroimage 9:63-80, 1999
7. Turner R, Howseman A, Rees GE, et al: Functional magnetic resonance imaging of the human brain: data acquisition and analysis. Exp Brain Res 123:5-12, 1998
8. Schloesser R, Hutchinson M, Joseffer S, et al: Functional magnetic resonance imaging of human brain activity in a verbal fluency task. J Neurol Neurosurg Psychiatry 64:492-8, 1998
9. Schloesser R, Simkowitz P, Bartlett EJ, et al: The study of neurotransmitter interactions using positron emission tomography and functional coupling. Clin Neuropharmacol 19:371-89, 1996
10. 11C raclopride in normal human subjects. Neuropsychopharmacology 18:18-25, 1998
11. 18F-N-methylspiroperidol PET studies to measure changes in antipsychotic drug D2 receptor occupancy in schizophrenic patients. Biol Psychiatry 23: 653-63, 1988
12. Abi-Dargham A, Gil R, Krystal J, et al: Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. Am J Psychiatry 155:761-7, 1998
13. Breier A, Su TP, Saunders R, et al. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc Natl Acad Sci U S A 94:2569-74, 1997
14. Laruelle M, Abi-Dargham A, van Dyck CH, et al: Single photon emission computerized tomography imaging of amphetamineinduced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci U S A 93:9235-40, 1996
15. Laruelle M, Abi-Dargham A, Gil R, et al. Increased dopamine transmission in schizophrenia: relationship to illness phases. Biol Psychiatry 46:56-72, 1999
16. Volkow ND, Fowler JS, Wolf AP, et al: Changes in brain glucose metabolism in cocaine dependence and withdrawal. Am J Psychiatry 148:621-6, 1991
17. 11C]deprenyl. J Neurochem 49:522-7, 1987
18. Fowler JS, Volkow ND, Logan J, et al: Slow recovery of human brain MAO B after L-deprenyl (Selegeline) withdrawal. Synapse 18:86-93, 1994
19. Volkow ND, Mullani N, Gould L, et al. Effects of acute alcohol intoxication on cerebral blood flow measured with PET. Psychiatry Res 24:201-9, 1988
20. 11C]WIN-35, 428. J Neurosci 18:8417-22, 1998
21. Bartlett EJ, Brodie JD, Simkowitz P, et al: The effect of a haloperidol challenge on regional brain metabolism in neurolepticresponsive and non-responsive schizophrenics. Am J Psychiatry 155:337-43, 1998
22. Furey ML, Pietrini P, Haxby JV, et al: Cholinergic stimulation alters performance and task-specific regional cerebral blood flow during working memory. Proc Natl Acad Sci U S A 94:6512-16, 1997
23. Amen DG, Stubblefield M, Carmicheal B, et al: Brain SPECT findings and aggressiveness. Ann Clin Psychiatry 8:129-37, 1996
24. Raine A, Meloy JR, Bihrle S, et al: Reduced prefrontal and increased subcortical brain functioning assessed using positron emission tomography in predatory and affective murderers. Behav Sci Law 16:319-32, 1998
25. Raine A, Lencz T, Bihrle, S, et al: Reduced prefrontal gray matter volume and reduced autonomic activity in antisocial personality disorder. Arch Gen Psychiatry 57:119-27, 2000
26. Tiihonen J, Kuikka JT, Bergstrom KA, et al. Single photon emission tomography imaging of monamine transporters in impulsive violent behavior. Eur J Nucl Med 24:1253-60, 1997
27. U.S. v. Gigante, 982 F.Supp. 140, 159 (E.D.N.Y. 1997)